C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics

Noga Orr, Maureen Collins, Shawn Novak, Isaac Melamed, Lawrence Steinman

Open source

DOI
10.1007/s10571-026-01736-4
Published
2026-05-19
Container
Cellular and Molecular Neurobiology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10571-026-01736-4,
  title = {C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics},
  author = {Noga Orr and Maureen Collins and Shawn Novak and Isaac Melamed and Lawrence Steinman},
  year = {2026},
  journal = {Cellular and Molecular Neurobiology},
  doi = {10.1007/s10571-026-01736-4},
  url = {https://doi.org/10.1007/s10571-026-01736-4}
}

RIS

TY  - JOUR
TI  - C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics
AU  - Noga Orr
AU  - Maureen Collins
AU  - Shawn Novak
AU  - Isaac Melamed
AU  - Lawrence Steinman
PY  - 2026
JO  - Cellular and Molecular Neurobiology
DO  - 10.1007/s10571-026-01736-4
UR  - https://doi.org/10.1007/s10571-026-01736-4
ER  - 

APA

Orr, N., Collins, M., Novak, S., Melamed, I., & Steinman, L. (2026). C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-026-01736-4

Source records